The Patent Finder

Pharmaleads

5 patents currently held · Updated Nov 20, 2026
7 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Recorded under 2 name spellings.

2
Ending by 2030
Jan 2028
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

No maintenance fee falls due on this company's record before Nov 20, 2027.

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.

Showing 1 to 5 of 5

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 7,875,436Peptide substrates recognizable by a botulinum toxin A, BoNT/A and the use thereof
In force
 · USPTO record
In forceUSPTO record
US 10,131,681Aminophosphinic derivatives that can be used in the treatment of pain
In force
 · USPTO record
In forceUSPTO record
US 10,688,113Methods of treating eye pain with aminophosphinic derivatives
In force
 · USPTO record
In forceUSPTO record
US 11,090,317Aminophosphinic derivatives for preventing and treating eye inflammation
In force
 · USPTO record
In forceUSPTO record
US 12,485,104Amino acid derivatives containing a disulfanyl group as an inhibitor of NEP and APN for the prevention and treatment of trigeminal nerve pain
In force
 · USPTO record
In forceUSPTO record
Also on record, not counted in the 5: 7 patents in force now held by others · 2 lapsed for an unpaid fee · 1 ended at full term. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

1 abandoned · 2 no status recorded

Showing 1 to 3 of 3, newest filing first. An application has no patent term. A term is computed when and if it grants, and appears on that patent's own page. Where no title is shown, the bulk publication record carries none and this site holds no USPTO file history for that application.

ApplicationTitleFiledStatus
15/779,220Nov 30, 2016No status recorded
15/001,752Agents for the Molecular Imaging of Serine-Protease in Human PathologiesJan 20, 2016Abandoned
13/810,870Jul 21, 2011No status recorded
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited